When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RYTM - European advisory group backs Rhythm Pharma's setmelanotide as Orphan Drug for rare inherited disorder
Rhythm Pharmaceuticals Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending Orphan Drug designation for Rhythm Pharmaceuticals' (RYTM-1.2%) setmelanotide for the potential treatment of Bardet-Biedl syndrome, a rare genetic disorder characterized by obesity, visual impairment, learning disabilities and kidney malfunction.
More news on: Rhythm Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,